Efficacy of JAK1/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency

MLA

Marie-Louise Frémond, et al. Efficacy of JAK1/2 Inhibition in the Treatment of Chilblain Lupus Due to TREX1 Deficiency. Oct. 2018. EBSCOhost, https://doi.org/10.1136/annrheumdis-2018-214037⟩.

APA

Marie-Louise Frémond, Aurélia Carbasse, Bénédicte Neven, Coralie Briand, Yanick J. Crow, Lucienne Chatenoud, Darragh Duffy, Vincent Bondet, Gillian I. Rice, Didier Bessis, & Stéphane Blanche. (2018). Efficacy of JAK1/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency. https://doi.org/10.1136/annrheumdis-2018-214037⟩

Chicago

Marie-Louise Frémond, Aurélia Carbasse, Bénédicte Neven, Coralie Briand, Yanick J. Crow, Lucienne Chatenoud, Darragh Duffy, et al. 2018. “Efficacy of JAK1/2 Inhibition in the Treatment of Chilblain Lupus Due to TREX1 Deficiency,” October. doi:10.1136/annrheumdis-2018-214037⟩.